bortezomib will improve the amount or effect of flibanserin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Improved flibanserin adverse results may arise if coadministered with various weak CYP3A4 inhibitors.Low illness activity has long been described and researched, and the most aspirational goal, remission, has